Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction

被引:103
作者
Grammatopoulos, Dimitris K. [1 ]
机构
[1] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England
基金
英国惠康基金;
关键词
alternative splicing; class-B1; GPCRs; CRH; CRH-R; MAPK; protein kinases; signalling; urocortin; PROTEIN-COUPLED RECEPTOR; FACTOR TYPE-1 RECEPTOR; HUMAN PREGNANT MYOMETRIUM; 7TH TRANSMEMBRANE DOMAIN; 1ST EXTRACELLULAR DOMAIN; NITRIC-OXIDE SYNTHASE; INHIBITS CELL-GROWTH; N-TERMINAL DOMAIN; FISH UROTENSIN-I; FACTOR-KAPPA-B;
D O I
10.1111/j.1476-5381.2011.01631.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During evolution, mammals have developed remarkably similar molecular mechanisms to respond to external challenges and maintain survival. Critical regulators of these mechanisms are the family of stress-peptides that consists of the corticotropin-releasing hormone (CRH) and urocortins (Ucns). These neuropeptides fine-tune integration of an intricate series of physiological responses involving the autonomic, endocrine, immune, cardiovascular and reproductive systems, which induce a spectrum of behavioural and homeostatic changes. CRH and Ucns exert their actions by activating two types of CRH receptors (CRH-R), CRH-R1 and CRH-R2, which belong to the class-B1 family of GPCRs. The CRH-Rs exhibit signalling promiscuity facilitated by their ability to couple to multiple G-proteins and regulate diverse intracellular networks that involve intracellular effectors such as cAMP and an array of PKs in an agonist and tissue-specific manner, a property that allows them to exert unique roles in the integration of homeostatic mechanisms. We only now begin to unravel the plethora of CRH-R biological actions and the transcriptional and post-translational mechanisms such as alternative mRNA splicing or phosphorylation-mediated desensitization developed to tightly control CRH-Rs biological activity and regulate their physiological actions. This review summarizes the current understanding of CRH-R signalling complexity and regulatory mechanisms that underpin cellular responses to CRH and Ucns.
引用
收藏
页码:85 / 97
页数:13
相关论文
共 98 条
[1]   Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells [J].
Aggelidou, E ;
Hillhouse, EW ;
Grammatopoulos, DK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3300-3305
[2]   Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction [J].
Assil, IQ ;
Qi, LJ ;
Arai, M ;
Shomali, M ;
Abou-Samra, AB .
BIOCHEMISTRY, 2001, 40 (05) :1187-1195
[3]   CROSS-REACTIVITY STUDIES OF CRF-RELATED PEPTIDES ON INSECT MALPIGHIAN TUBULES [J].
AUDSLEY, N ;
KAY, I ;
HAYES, TK ;
COAST, GM .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1995, 110 (01) :87-93
[4]   CRF and CRF receptors: Role in stress responsivity and other behaviors [J].
Bale, TL ;
Vale, WW .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :525-557
[5]   Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology [J].
Bangasser, D. A. ;
Curtis, A. ;
Reyes, B. A. S. ;
Bethea, T. T. ;
Parastatidis, I. ;
Ischiropoulos, H. ;
Van Bockstaele, E. J. ;
Valentino, R. J. .
MOLECULAR PSYCHIATRY, 2010, 15 (09) :896-904
[6]   Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain [J].
Berger, H. ;
Heinrich, N. ;
Wietfeld, D. ;
Bienert, M. ;
Beyermann, M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (07) :942-947
[7]   Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain [J].
Beyermann, M. ;
Heinrich, N. ;
Fechner, K. ;
Furkert, J. ;
Zhang, W. ;
Kraetke, O. ;
Bienert, M. ;
Berger, H. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (06) :851-859
[8]   Urocortin-II and Urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart [J].
Brar, BK ;
Jonassen, AK ;
Egorina, EM ;
Chen, A ;
Negro, A ;
Perrin, MH ;
Mjos, OD ;
Latchman, DS ;
Lee, KF ;
Vale, W .
ENDOCRINOLOGY, 2004, 145 (01) :24-35
[9]   Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides [J].
Brar, BK ;
Chen, A ;
Perrin, MH ;
Vale, W .
ENDOCRINOLOGY, 2004, 145 (04) :1718-1729
[10]   Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors [J].
Cantarella, G ;
Lempereur, T ;
Lombardo, G ;
Chiarenza, A ;
Pafumi, C ;
Zappalà, G ;
Bernardini, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :837-844